PUBLISHER: Meticulous Research | PRODUCT CODE: 2178431
PUBLISHER: Meticulous Research | PRODUCT CODE: 2178431
The global environmental DNA (eDNA) market was valued at USD 168.4 million in 2025. The market is estimated at USD 192.7 million in 2026 and is projected to reach USD 676.5 million by 2036, at a CAGR of 13.4% during the forecast period 2026-2036. This report provides a detailed assessment of the market, covering biodiversity policy and nature disclosure, sampling and analysis technologies, the value chain, standards and regulatory acceptance, funding, cost per sample, the competitive landscape, and future growth opportunities.
The market, also called the eDNA biomonitoring or eDNA biodiversity monitoring market, includes the services, consumables, equipment, and software that capture and analyze genetic material that organisms leave behind in water, soil, sediment, air, and other samples, so that species can be identified without being seen, caught, or disturbed. Targeted qPCR and digital PCR assays, NGS-based DNA metabarcoding of whole communities, emerging shotgun metagenomic and environmental RNA methods, filters, preservation and extraction kits, portable and autonomous samplers, laboratory services, and bioinformatics, reference databases, and data platforms are all in scope. Wastewater surveillance of human pathogens, food authenticity testing, clinical microbiome analysis, and environmental monitoring that does not use DNA are excluded.
According to the TNFD 2026 Status Report published in September 2026, more than 1,000 organizations from 56 countries and jurisdictions have issued TNFD-aligned disclosures, about twice the prior year's number, and 802 organizations have committed to adopt its recommendations, among them financial institutions managing USD 26.6 trillion in assets, a sign of fast-rising corporate demand for nature data. Standards are also maturing: in July 2026, the International Organization for Standardization published ISO 17805:2026, the first global standard covering how eDNA is sampled, captured, and preserved from water. According to the Kunming-Montreal Global Biodiversity Framework agreed in December 2022, countries aim to protect 30% of land and sea by 2030, a target that requires monitoring at a scale field surveys alone cannot deliver.
Market Dynamics
Scalable biodiversity monitoring is the main driver of the environmental DNA (eDNA) market, because public bodies, businesses, and conservation groups need ecosystem data to track progress against national and global targets, and one water or soil sample can reveal hundreds of species without relying on scarce taxonomists. Nature-related corporate disclosure is the fastest-growing source of demand, since frameworks such as TNFD ask companies to assess site-level impacts and dependencies on nature, and eDNA gives auditable data across many sites. Environmental impact assessment and permitting add demand from offshore wind, hydropower, mining, oil and gas, and infrastructure developers that must set biodiversity baselines and track impacts; vessel-based marine sampling covers large offshore areas more efficiently than trawl, grab, or diver surveys. It also spots invasive species early and confirms rare species without capture.
eDNA shows that a species' DNA is present but does not directly measure abundance, age, or health, and DNA can drift with currents or persist after a species has left, which can create false detections, while degraded or inhibited samples can miss species that are present. Results therefore often need to be paired with traditional surveys and expert review. Regulatory acceptance is uneven across countries, species, and uses, as many assessment rules still specify conventional survey methods. Reference databases lack sequences for many invertebrates, fungi, and tropical and marine species, and differences in sampling, primers, sequencing, and bioinformatics limit comparability, while ISO 17805:2026 does not yet cover sediment, biofilm, or passive sampling.
Nature markets, biodiversity credits, and net gain verification are a significant opportunity, as England's mandatory biodiversity net gain, introduced in 2024, and new credit schemes need repeatable proof of biodiversity change. Autonomous samplers on buoys, vessels, and underwater vehicles, portable sequencers, and airborne eDNA collection can expand monitoring to remote areas, and combining eDNA with AI, satellite imagery, bioacoustics, and camera traps creates broader biodiversity intelligence. Fisheries, aquaculture, and water utilities add further openings. Key trends include the standardization of eDNA methods, the move from research toward commercial and regulatory monitoring, and rising investment in biodiversity technology companies.
Segment Analysis
The report analyzes the market by offering, technology, sample type, application, end user, and geography, helping stakeholders identify the most attractive areas for service, product, and regional investment.
By offering, the environmental DNA (eDNA) market is segmented into services, kits and consumables, instruments, and software and data platforms. Services, covering laboratory analysis and sampling and survey work, are expected to account for the largest share in 2026, as agencies, consultancies, and companies depend on specialist eDNA laboratories for analysis and interpretation, and NatureMetrics alone reports serving more than 600 organizations across 110 countries. Software & data platforms are expected to grow at the highest CAGR, driven by demand for biodiversity intelligence tools that combine eDNA with geospatial and acoustic data and by the need for standardized outputs for nature disclosure. Kits & consumables should benefit from standardized sampling under ISO 17805:2026, while instruments grow with autonomous and portable samplers and sequencers.
By technology, the environmental DNA (eDNA) market is segmented into DNA metabarcoding, qPCR and digital PCR, shotgun metagenomics and environmental RNA, and other technologies. DNA metabarcoding is expected to hold the largest share in 2026, as it can identify hundreds of species in one sample and has become the preferred method for biodiversity monitoring, impact assessment, and corporate reporting. Shotgun metagenomics & environmental RNA is expected to grow at the highest CAGR, as metagenomics can add broader taxonomic and functional information and environmental RNA can indicate which organisms were recently active. qPCR and digital PCR remain the main tools for targeted detection of invasive and protected species.
By sample type, the environmental DNA (eDNA) market is segmented into water (freshwater and marine water), soil and sediment, air, and other samples. Water is expected to account for the largest share in 2026, since sampling rivers, lakes, wetlands, and oceans is efficient, water eDNA is well established for fish, amphibian, and invasive species monitoring, and ISO 17805:2026 now standardizes water sampling. Air is expected to grow at the highest CAGR, as airborne collection is being developed to monitor terrestrial plants and animals across large areas. Soil & sediment is also set for strong growth through soil biodiversity and land-based nature assessments.
By application, the environmental DNA (eDNA) market is segmented into biodiversity monitoring and assessment, invasive and endangered species detection, environmental impact assessment and permitting, nature-related corporate reporting and nature markets, fisheries and aquaculture management, and water quality and ecosystem health. In 2026, biodiversity monitoring & assessment is set to lead, reflecting broad use in national and regional monitoring programs, research, and conservation. Nature-related corporate reporting & nature markets is expected to grow at the highest CAGR, supported by the doubling of TNFD-aligned disclosures, biodiversity net gain rules, and emerging biodiversity credit markets that require verifiable data. Invasive species work, such as tracking invasive carp and mussels, and protected species surveys, such as great crested newt checks in the U.K., remain established regulatory uses.
By end user, the environmental DNA (eDNA) market is segmented into government and environmental agencies, corporations, environmental consultancies, academic and research institutes, and conservation organizations and NGOs, with corporate demand covering energy and utility, mining, construction, food and farming, and financial companies. Government & environmental agencies are expected to account for the largest share in 2026, since agencies responsible for the environment, fisheries, and water run most eDNA monitoring and regulatory programs. Corporations are expected to grow at the highest CAGR, driven by nature disclosure, impact assessment, biodiversity net gain, and investor requests for site-level nature data. Consultancies increasingly bundle eDNA with traditional surveys.
Regional Analysis
The report covers Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa, spanning 19 countries, the Nordic countries, and four rest-of-region groups. The regional analysis considers biodiversity policy, regulatory acceptance, disclosure activity, resource development, and provider presence.
Europe is expected to remain the largest regional environmental DNA (eDNA) market in 2026, backed by the EU Nature Restoration Law, the biodiversity net gain duty in England, official use of eDNA for protected species checks such as U.K. great crested newt surveys, a strong base of specialist laboratories including NatureMetrics and SPYGEN, and high corporate interest in nature reporting. Water and biodiversity programs and offshore wind projects support demand in the main country markets, and the adoption of ISO 17805:2026 as a European standard (EN ISO 17805:2026) should widen official use. North America holds a significant share, as federal and state agencies use eDNA to track invasive carp in the Great Lakes, manage fisheries, and monitor endangered species, and providers such as Jonah Ventures, Illumina, Thermo Fisher Scientific, and Smith-Root are based there.
Asia-Pacific is expected to grow at the highest CAGR during the forecast period, driven by high biodiversity, large infrastructure and mining projects, rising corporate disclosure, and expanding national monitoring. Japan has a strong eDNA research base, biosecurity and conservation agencies in Australia and New Zealand, where Wilderlab operates, are active users, and demand is expected to rise quickly in China, Indonesia, and the rest of Southeast Asia. In Latin America, biodiversity, mining, and energy projects in Brazil, Chile, Peru, and Colombia support demand, while mining, infrastructure, and conservation programs support adoption in the Middle East & Africa.
Competitive Landscape
The report provides a detailed review of the competitive landscape, covering key growth strategies, competitive benchmarking, the competitive dashboard (market leaders, market differentiators, vanguards, and emerging players), and market share/rank analysis by key player for 2025. Company profiles include business overviews, financial overviews, eDNA and product/service portfolios, strategic developments, and SWOT analyses.
The environmental DNA (eDNA) market is fragmented, with specialist laboratories, biodiversity data firms, consultancies, sampler makers, and sequencing and PCR suppliers each active in different regions and uses. Providers compete on detection accuracy, database coverage, accreditation, turnaround, cost per sample, and reporting tools. Leading companies are adding laboratory capacity, building AI-enabled biodiversity platforms, extending reference databases, adopting standard methods, and expanding abroad. In January 2025, NatureMetrics, with its own laboratories in the U.K. and Canada and a partner site in Indonesia, reported a EUR 24.3 million Series B round, led by Just Climate, EDF Pulse Ventures, and the Monaco ReOcean Fund, to grow its Nature Intelligence Platform.
Key companies profiled in the report include NatureMetrics Ltd (U.K.), SPYGEN (France), Jonah Ventures LLC (U.S.), Wilderlab NZ Ltd (New Zealand), Smith-Root, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Oxford Nanopore Technologies plc (U.K.), and QIAGEN N.V. (Netherlands).
How This Report Helps
Key Questions Answered